A CAR RNA FISH assay to study functional and spatial heterogeneity of chimeric antigen receptor T cells in tissue
Abstract
Chimeric antigen receptor (CAR) T cells are engineered cells used in cancer therapy and are studied to treat infectious diseases. Trafficking and persistence of CAR T cells is an important requirement for efficacy to target cancer. Here, we describe a CAR RNA FISH histo-cytometry platform combined with a random reaction seed image analysis algorithm to quantitate spatial distribution and in vivo functional activity of a CAR T cell population at a single cell resolution for preclinical models. In situ, CAR T cell exhibited a heterogenous effector gene expression and this was related to the distance from tumor cells, allowing a quantitative assessment of the potential in vivo effectiveness. The platform offers the potential to study immune functions of genetically engineered cells in situ with their target cells in tissues with high statistical power and thus, can serve as an important tool for preclinical assessment of CAR T cell effectiveness. Brief summaryWe developed an imaging platform and analysis pipeline to study large populations of engineered cells at a single cell level in situ. One Sentence SummaryWe developed a CAR RNA FISH assay to study chimeric antigen receptor T cell trafficking and function in mouse tissue.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CARs are organized in nanodomains in the plasma membrane of T cells that accumulate at tumor contact sites
C. Verbruggen, L. Gehrke, … M. Sauer·bioRxiv·Jul 19, 2023
- Cellular behavior analysis from live-cell imaging of TCR T cell-cancer cell interactions
Archit Verma, Changhua Yu, … Barbara Elizabeth Engelhardt·bioRxiv·Nov 19, 2024
- Screening of a pooled library of chimeric antigen receptor T cells based on secretory function
Citradewi Soemardy, Anna Huo-Chang Mei, … Dino Di Carlo·bioRxiv·Jul 2, 2025
- CellCage™ Technology Enables High-throughput Isolation of Defined Cell Combinations to Resolve the Determinants of CAR-T mediated Cytotoxicity
Richard G. Yau, Shreya S. Deshmukh, … Gary P. Schroth·bioRxiv·Aug 25, 2026
- Titering of Chimeric Antigen Receptors on CAR T Cells enabled by a Microfluidic-based Dosage-Controlled Intracellular mRNA Delivery Platform
Y.-H. Chen, R. Jiang, A. P. Lee·bioRxiv·Mar 14, 2023
- Imaging CRISPR-Edited CAR-T Cell Therapies with Optical and Positron Emission Tomography Reporters
Rafael E. Sanchez‐Pupo, John Joseph Kelly, … John Andrew Ronald·TheranosticsPeer-reviewed·Jan 1, 2026